https://www.malattierare.eu/ 1.00 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/pages/editore/ 0.80 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/pages/comitatoRedazione/ 0.80 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/pages/caratteristicheTecniche/ 0.80 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/download/Listino2026.pdf 0.60 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/download/brochure.pdf 0.80 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/pages/videoPodcast/ 0.80 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/pages/rivista/ 0.80 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/download/2026_1/MR_1_2026.pdf 0.60 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/pages/rivista/Conoscenza-rete-e-comunit-per-costruire-una-scienza-partecipata-idA331 0.60 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/pages/rivista/Tracheomalacia-e-atresia-dellesofago-una-associazione-complessa-di-condizioni-rare-idA332 0.60 2026-07-28T14:42:17+02:00 https://www.malattierare.eu/pages/rivista/Osteogenesi-imperfetta-percorsi-riabilitativi-idA333 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Acondroplasia-e-vosoritide-nuovo-paradigma-di-gestione-idA334 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Lavoro-e-disabilit-la-gestione-delle-malattie-rare-come-nuova-sfida-per-una-medicina-del-lavoro-inclusiva-idA335 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Un-raro-caso-di-neuromielite-di-Devic-con-ritenzione-urinaria-acuta-idA336 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Osteogenesi-imperfetta-tipo-V-diagnosi-clinico-radiologica-in-un-giovane-adulto-idA337 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/La-linfoscintigrafia-nel-linfedema-primitivo-idA338 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Epidermolisi-bollosa-distrofica-elementi-clinici-dismorfologici-e-terapeutici-in-un-caso-pediatrico-idA339 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Il-potenziamento-cognitivo-precoce-come-intervento-di-supporto-nella-sindrome-di-Sanfilippo-idA340 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Osteogenesi-imperfetta-trattamenti-farmacologici-innovativi-idA341 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/TransplantChild-la-rete-europea-di-riferimento-per-i-trapianti-pediatrici-idA342 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/AI-e-comunicazione-nelle-malattie-rare-opportunit-e-limiti-idA343 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Palopegteriparatide-nellipoparatiroidismo-evidenze-real-life-dallesperienza-francese-idA344 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/AISA-da-oltre-40-anni-al-fianco-delle-persone-con-atassia-idA345 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2026 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2025 0.60 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/download/2025_3/MR_3_2025.pdf 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Epilessie-rare-in-un-mondo-convulsivante-idA319 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Atassia-di-Friedreich-quadro-clinico-e-prospettive-terapeutiche-idA320 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Dieta-chetogenica-storia-applicazioni-e-prospettive-nella-gestione-delle-epilessie-farmacoresistenti-idA321 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/COVID-19-cinque-anni-dopo-lezioni-apprese-e-opportunit-mancate-idA322 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Approccio-riabilitativo-personalizzato-in-un-caso-pediatrico-di-encefalopatia-da-mutazione-CTNNB1-idA323 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Edema-midollare-osseo-facciamo-un-po-di-chiarezza-idA324 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-associata-a-SATB2-idA325 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Omaveloxolone-una-nuova-frontiera-nel-trattamento-dellatassia-di-Friedreich-idA326 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Levoluzione-della-diagnosi-in-genetica-tra-tecnologie-e-conoscenza-idA327 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Epilessie-rare-attivit-del-gruppo-di-studio-LICE-ed-azioni-volte-al-miglioramento-dellassistenza-idA328 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Epilessie-metaboliche-nuovi-biomarcatori-diagnostici-e-strategie-terapeutiche-emergenti-idA329 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/SATB2-Italia-APS-la-forza-della-rarit-idA330 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/download/2025_2/MR_2_2025.pdf 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Limportanza-di-appartenere-ad-una-comunit-worldwide-idA306 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Ipertensione-arteriosa-polmonare-diagnosi-precoce-e-strategia-terapeutica-idA307 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Le-sindromi-da-edema-midollare-idiopatico-idA308 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Porpora-trombocitopenica-immune-idA309 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Affettivit-e-sessualit-nelle-malattie-rare-idA310 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Gemelli-monocoriali-con-sindrome-di-Dravet-due-vite-le-stesse-sfide-idA311 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Malformazioni-artero-venose-polmonari-idA312 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-di-Alagille-idA313 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Fenilchetonuria-formazione-neuropsicologica-per-lindividuazione-precoce-dei-segni-di-decadimento-cognitivo-idA314 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Maralixibat-il-primo-inibitore-del-trasportatore-ileale-degli-acidi-biliari-rimborsato-dal-SSN-per-la-sindrome-di-Alagille-idA315 0.40 2026-07-28T14:42:18+02:00 https://www.malattierare.eu/pages/rivista/Ipertensione-arteriosa-polmonare-stato-dellarte-delle-terapie-farmacologiche-idA316 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Pegcetacoplan-in-pazienti-con-EPN-lesperienza-italiana-in-pratica-clinica-idA317 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Associazione-Italiana-MAV-Odv-rari-insieme-idA318 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/download/2025_1/MR_1_2025.pdf 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Tecnologia-e-psiche-lalleanza-tra-lintelligenza-artificiale-e-lintelligenza-umana-ai-tempi-del-welfare-idA291 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Implicazioni-psicologiche-nel-lupus-eritematoso-sistemico-paradigma-di-una-malattia-rara-cronica-e-complessa-idA292 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Fanconi-idA293 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Obesit-genetiche-quando-e-perch-sospettarle-idA294 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Intelligenza-artificiale-e-malattie-rare-idA295 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Un-insolito-caso-di-diarrea-cela-un-tumore-neuroendocrino-atipico-occulto-idA296 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Quando-locchio-fa-da-spia-emeralopia-e-deficit-refrattivi-guidano-la-diagnosi-di-una-malattia-rara-multisistemica-idA297 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Fibroelastosi-pleuro-parenchimale-idiopatica-idA298 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Waardenburg-idA299 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Le-novit-scientifiche-per-le-malattie-genetiche-non-diagnosticate-idA300 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Nuove-prospettive-farmacologiche-nella-gestione-delle-obesit-genetiche-focus-su-setmelanotide-idA301 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Il-network-internazionale-per-le-malattie-non-diagnosticate-un-impegno-globale-per-la-ricerca-e-la-diagnosi-nelle-malattie-rare-idA302 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/La-rete-internazionale-delle-malattie-non-diagnosticate-idA303 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Impatto-dellacondroplasia-sulla-qualit-di-vita-il-Progetto-chAnge-idA304 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/LAssociazione-Prader-Willi-Italia-idA305 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2024 0.60 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/download/2024_3/MR_3_2024.pdf 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Limportanza-di-funzionare-idA276 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Le-malformazioni-congenite-delle-vie-aeree-polmonari-idA277 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/La-granulomatosi-eosinofila-con-poliangioite-idA278 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Nuove-frontiere-diagnostiche-nella-malattia-di-Pompe-lo-screening-neonatale-idA279 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/La-diagnosi-funzionale-nelle-malattie-rare-uno-sforzo-decisivo-idA280 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/La-pediatria-della-disabilita-tutti-convocati-idA4 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Il-naso-che-parla-la-rinorrea-cronica-come-segnale-di-una-malattia-rara-sistemica-idA281 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Malattia-di-Erdheim-Chester-un-caso-clinico-complesso-idA282 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-di-Koolen-de-Vries-idA283 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Malattie-cardiovascolari-in-pazienti-con-ipercolesterolemia-familiare-omozigote-differenze-di-genere-idA284 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Neridronato-intramuscolare-quando-una-nuova-via-di-somministrazione-pu-rivoluzionare-la-vita-dei-pazienti-idA285 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Trattamento-farmacologico-della-granulomatosi-eosinofila-con-poliangioite-idA286 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/La-galenica-clinica-nelle-malattie-rare-un-esempio-di-approccio-terapeutico-personalizzato-nella-sindrome-VEXAS-idA287 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/JARDIN-coltivare-il-futuro-delle-malattie-rare-in-Europa-idA288 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Ipercolesterolemia-familiare-omozigote-efficacia-sicurezza-e-tollerabilit-di-inclisiran-idA289 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Rari-ma-non-soli-limportanza-delle-associazioni-nella-gestione-delle-malattie-rare-idA290 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/download/2024_2/MR_2_2024.pdf 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Linsostenibile-sofferenza-della-malattia-rara-idA257 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Ipermobilit-articolare-come-orientarsi-idA258 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Anemia-di-Diamond-Blackfan-idA259 0.40 2026-07-28T14:42:19+02:00 https://www.malattierare.eu/pages/rivista/Tofersen-la-prima-terapia-efficace-per-la-SLA-idA260 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/La-donazione-di-sangue-e-plasma--un-gesto-semplice-ma-straordinario-idA261 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Le-sindromi-di-Ehlers-Danlos-idA262 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-CHOPS-il-caso-di-una-paziente-con-diagnosi-tardiva-idA263 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/PKU-gestione-del-paziente-in-fase-di-transizione-dallet-pediatrica-a-quella-adulta-idA264 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-nutcracker-idA265 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-di-Mowat-Wilson-idA266 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Evinacumab-una-nuova-strategia-nel-trattamento-dellipercolesterolemia-familiare-omozigote-idA267 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Malattia-di-Pompe-nuove-prospettive-terapeutiche-idA268 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Ravulizumab-una-nuova-opportunit-terapeutica-nella-sindrome-emolitico-uremica-atipica-idA269 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Neridronato-intramuscolare-ed-algodistrofia-una-novit-a-misura-di-paziente-idA270 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/ERN-SKIN-la-rete-di-riferimento-per-le-malattie-cutanee-rare-idA271 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Il-ruolo-di-lomitapide-nel-trattamento-della-sindrome-chilomicronemica-familiare-idA272 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Aspetti-etici-legati-allo-screening-neonatale-idA273 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Tofersen-un-nuovo-spiraglio-nella-lotta-contro-la-SLA-idA274 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/La-donazione-di-sangue-un-atto-di-solidariet-e-altruismo-idA275 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/download/2024_1/MR_1_2024.pdf 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Sette-anni-di-rara-attivit-idA244 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Feocromocitoma-manifestazioni-sindromiche-idA245 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Sostenibilit-dei-trattamenti-per-le-malattie-rare-idA246 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/I-tumori-ereditari-del-colon-retto-la-sindrome-di-Lynch-idA247 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/La-carenza-di-infermieri-e-la-lotta-contro-le-malattie-rare-ripensando-alle-sfide-del-futuro-idA248 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Allestimento-e-somministrazione-di-acitretina-orale-per-il-trattamento-dellittiosi-di-Arlecchino-idA249 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/La-transizione-dalla-pediatria-alla-medicina-delladulto-un-caso-di-mucopolisaccaridosi-IV-A-idA250 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Un-caso-di-macrocerebellum-isolato-idA251 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-CODAS-una-nuova-entit-nosologica-da-considerare-in-diagnosi-differenziale-per-cataratta-congenita-idA252 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Infermieri-di-ricerca-nelle-malattie-rare-idA253 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Vosoritide-terapia-innovativa-per-lacondroplasia-idA254 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Medicina-di-precisione-e-malattie-rare-idA255 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Donne-e-rarit-idA256 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2023 0.60 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/download/2023_3/MR_3_2023.pdf 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/La-forza-del-pensiero-per-vincere-il-male-idA230 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/La-diagnosi-genetico-molecolare-dellemocromatosi-HFE-correlata-idA231 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Cause-rare-di-ipertensione-iperaldosteronismo-primitivo-idA232 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Accesso-ai-farmaci-per-le-malattie-rare-come-ridurre-le-differenze-regionali-idA233 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Essere-Malati--faticoso-idA234 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/La-malattia-di-Rosai-Dorfman-una-rara-tra-le-rare-idA235 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/La-terapia-con-pegvaliase-nella-fenilchetonuria-efficacia-e-gestione-degli-eventi-avversi-idA236 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Daratumumab-in-monoterapia-per-il-trattamento-dellamiloidosi-AL-idA237 0.40 2026-07-28T14:42:20+02:00 https://www.malattierare.eu/pages/rivista/Acondroplasia-e-diagnosi-prenatale-idA238 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Aym-Gripp-idA239 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Evoluzione-della-terapia-per-il-deficit-di-GH-idA240 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Risdiplam-il-nuovo-farmaco-orale-per-il-trattamento-della-SMA-linnovazione-a-domicilio-idA241 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Screening-dellesoma-e-trapianto-renale-idA242 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Smith-Magenis-Italia-Onlus-idA243 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/download/2023_2/MR_2_2023.pdf 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Ancora-orfani-dopo-40-anni-idA217 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Mutazioni-nei-geni-COL4A1-A2-idA218 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Behet-una-patologia-rara-da-non-sottovalutare-idA219 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Pensa-globale-agisci-locale-la-carenza-di-emoderivati-e-le-malattie-rare-idA220 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Terapia-enzimatica-sostitutiva-impatto-neurocognitivo-psicosociale--e-sulla-qualita-di-vita-dei-pazienti-con-PKU-idA221 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Diventa-anche-tu-figo-inizia-a-donare-idA222 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Malattia-di-Castleman-un-enigma-diagnostico-e-terapeutico-idA223 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Amiloidosi-da-transtiretina-iter-diagnostico-e-approccio-terapeutico-idA224 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-CHARGE-idA225 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/La-terapia-farmacologica-con-vosoritide-nellacondroplasia-presa-in-carico--e-prospettive-future-idA226 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/La-carenza-dei-farmaci-lo-stato-dellarte-idA227 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Trapianto-di-organi-e-malattie-rare-idA228 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Associazione-Famiglie-COL4A1-A2-APS-idA229 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/download/2023_1/MR_1_2023.pdf 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Storia-di-un-tempo-sospeso-idA203 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Novit-nella-terapia-dellamiloidosi-AL-idA204 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Prevenzione-primaria-in-ambito-materno-infantile-gli-esiti-avversi-della-riproduzione-e-le-malformazioni-congenite-idA205 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Fenilchetonuria-e-nuove-prospettive-terapeutiche-idA206 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/COVID-19-in-eta-pediatrica-idA207 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Malattia-IgG4-correlata-polidistrettuale-diagnosi-definitiva-mediante-biopsia-renale-e-approccio-terapeutico-idA208 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/La-malattia-da-IgG4-idA176 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Pallister-Killian-idA209 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Osteoporosi-e-innovazione-farmacologica-il-ruolo-di-romosozumab-idA210 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Nuovo-scenario-terapeutico-per-il-trattamento-dellemofilia-A-emicizumab-idA211 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Il-segno-del-dente-molare-idA212 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Le-necessit-socio-assistenziali--dei-pazienti-europei-affetti-da-malattie-rare-metaboliche-dati-italiani-idA213 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Un-testo-innovativo-per-accogliere--i-bambini-con-disturbo-complesso-della-comunicazione-idA214 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/VASCERN-la-rete-di-riferimento-europea-sulle-malattie-vascolari-rare-idA215 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/Un-progetto-per-lassistenza-integrata-alle-persone-con-emofilia-in-Lombardia-idA216 0.40 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2022 0.60 2026-07-28T14:42:21+02:00 https://www.malattierare.eu/download/2022_3/MR_3_2022.pdf 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Re-imparare-a-comunicare-idA188 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Colangite-biliare-primitiva-idA189 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Alcaptonuria-focus-su-una-malattia-genetica-ultra-rara-idA190 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Miastenia-gravis-idA191 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Il-ruolo-dellindustria-del-farmaco-nello-sviluppo-delle-linee-guida-per-le-malattie-rare-idA194 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Rachitismo-ipofosfatemico-X-linked-nuovi-approcci-terapeutici-nellambito-delle-terapie-biologiche-idA193 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Gemelli-affetti-da-retinoschisi-congenita-X-linked-e-sindrome-di-Brown-idA195 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-KBG-idA196 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Terapie-a-RNA-quando-la-copia-e-meglio-delloriginale-idA197 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Lalcaptonuria-il-lungo-percorso-per-la-terapia-eziologica-idA198 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Vediamo-solo-quello-che-conosciamo-destrocardia-e-situs-viscerum-inversus-idA199 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Verso-una-terapia-personalizzata-per-la-miastenia-gravis-idA200 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/ERN-BOND-la-rete-di-riferimento-europea-delle-malattie-rare-scheletriche-idA201 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/aimAKU---Associazione-Italiana-Malati-di-Alcaptonuria-idA202 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/download/2022_2/MR_2_2022.pdf 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Carrozzeria-comandi-e-motore-idA175 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Emocromatosi-giovanile-idA177 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Fibrosi-cistica-e-nuovi-farmaci-inizio-della-fine-idA178 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Distrofia-miotonica-congenita-un-esempio-di-presa-in-carico-multidisciplinare-sin-dalla-nascita-idA179 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-pseudo-Bartter-nella-fibrosi-cistica-idA180 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Niikawa-Kuroki-idA181 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Distrofia-muscolare-di-Duchenne-nuovi-standard-di-cura-e-prospettive-terapeutiche-idA182 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Le-terapie-innovative-nel-trattamento-della-fibrosi-cistica-idA174 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Le-ragioni-farmacologiche-e-farmaco-tecnologiche-delle-differenze-tra-farmaci-il-caso-della-trientina-idA183 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/MPS-tipo-I-ruolo-della-risonanza-magnetica-cerebrale-e-spinale-nella-diagnosi-e-nel-follow-up-idA184 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Lo-stato-dellarte-della-terapia-antibiotica-per-via-inalatoria-in-fibrosi-cistica-idA185 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/ERN-LUNG-la-rete-europea-delle-malattie-rare-del-sistema-respiratorio-idA186 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/La-Consulta-neuromuscolare-una-efficace-idea-di-collaborazione-tra-le-associazioni-idA187 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/download/2022_1/MR_1_2022.pdf 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Via-da-questepoca-sospesa-idA160 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Colangite-sclerosante-primitiva-idA161 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Ipertensione-arteriosa-polmonare-idA162 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Colangiocarcinoma-nuove-prospettive-terapeutiche-idA163 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/La-terapia-domiciliare-nelle-malattie-rare-idA164 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-da-anticorpi-antifosfolipidi-ad-interessamento-neurologico-diagnosi-e-strategie-terapeutiche-idA165 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Alfa-mannosidosi-una-malattia-da-riconoscere-scoprire-e-curare-idA166 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Patologie-rare-della-cute-gestione-multidisciplinare-nel-pemfigo-volgare-idA167 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-di-Morquio-MPS-IV-limportanza-di-una-diagnosi-precoce-idA168 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/I-processi-comunicativi-nello-Screening-Neonatale-Esteso-idA169 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Le-nuove-frontiere-della-terapia-genica-il-modello-dellemofilia-B-idA170 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Il-vaccino-anti-COVID-19-nelle-malattie-rare-cosa-dobbiamo-sapere-idA171 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/Screening-neonatale-la-situazione-attuale-in-51-Paesi-della-regione-Europea-idA172 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/La-Giornata-delle-Malattie-Rare-idA173 0.40 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2021 0.60 2026-07-28T14:42:22+02:00 https://www.malattierare.eu/download/2021_3/MR_3_2021.pdf 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Conoscenza-ee-liberta-idA146 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Epatite-autoimmune-idA147 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Le-laminopatie-muscolari-scheletriche-idA148 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Bisfosfonati-ed-osteogenesi-imperfetta-idA149 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Le-reti-di-riferimento-europeo-per-le-malattie-rare-update-e-programmi-per-il-futuro-idA150 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Significativo-arresto-della-crescita-ponderale-non-solo-genetica-idA151 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Impatto-della-terapia-con-empagliflozin-su-due-pazienti-con-GSD1b-e-MICI-idA152 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-Xia-Gibbs-una-rara-forma-sindromica-di-disabilita-intellettiva-idA153 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Lutilizzo-dei-sensori-inerziali-nel-follow-up-delle-malattie-rare-idA154 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Levoluzione-della-terapia-per-la-SMA-da-nusinersen-alla-terapia-genica-idA155 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/I-Registri-di-Malattie-Rare-idA156 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/IPINet-il-registro-italiano-delle-immunodeficienze-primitive-idA157 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/ERN-e-COVID-19-valutazione-della-vaccinazione-nei-pazienti-con-MR-complesse-del-tessuto-connettivo-idA158 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Il-contributo-dei-rappresentanti-di-pazienti-nelle-ERN-idA159 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/download/2021_2/MR_2_2021.pdf 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Liberi-idA79 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Immunodeficienza-comune-variabile-idA80 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Novita-sulla-sindrome-del-Cri-du-Chat-un-modello-di-studio-per-una-malattia-rara-idA81 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Malattie-rare-modalita-di-accesso-ai-farmaci-orfani-innovativi-e-off-label-idA82 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Calcolosi-renale-secondaria-a-cistinuria-racconto-di-un-percorso-ad-ostacoli-tra-diagnosi-e-cura-idA83 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Trentacinque-anni-di-follow-up-in-un-paziente-affetto-da-porfiria-epatoeritropoietica-idA84 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Fare-luce-e-diagnosi-sulla-neuropatia-ottica-ereditaria-di-Leber-idA85 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Crisponisudorazione-indotta-dal-freddo-idA86 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Empagliflozin-nella-glicogenosi-tipo-Ib-un-successo-della-medicina-traslazionale-idA87 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/La-gestione-dei-farmaci-esteri-normativa-di-riferimento-e-fasi-di-acquisizione-idA88 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Empagliflozin-e-glicogenosi-Ib-un-caso-clinico-idA89 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Immunoglobuline-sottocute-nelle-PID-idA90 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/RITA-la-ERN-per-le-immunodeficienze-e-le-malattie-autoinfiammatorie-ed-autoimmuni-rare-idA91 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/AIP---Associazione-Immunodeficienze-Primitive-idA92 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/download/2021_1/MR_1_2021.pdf 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Chiari-scuri-di-questanno-horribilis-idA1 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/La-malattia-di-Whipple-idA2 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/La-sclerosi-sistemica-idA3 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Malattia-di-Fabry-con-cardiomiopatia-ipertrofica-idA5 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Una-insufficienza-cardiaca-ad-eziologia-sospetta-idA6 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-CDKL5-e-sindromi-Rett-like-idA7 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Patisiran-la-prima-terapia-RNAi-per-il-trattamento-dellamidoilosi-ereditaria-mediata-dalla-transtiretina-idA8 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Coinvolgimento-cardiologico-nella-malattia-di-Fabry-revisione-della-letteratura-idA9 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Limpiego-dellimaging-nella-diagnosi-e-nella-gestione-dellamiloidosi-cardiaca-idA10 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/ERN-EuroBloodNet-la-Rete-di-Riferimento-Europea-per-le-malattie-ematologiche-rare-idA11 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/La-transizione-nelle-malattie-rare-il-punto-di-vista-di-pazienti-e-famiglie-idA12 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2020 0.60 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/download/2020_3/MR_3_2020.pdf 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/La-ventilazione-meccanica-non-invasiva-nei-pazienti-pediatrici-con-malattie-rare-indicazioni-e-monitoraggio-idA14 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/La-fibrosi-cistica-idA15 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/COVID-19-e-malattie-rare-i-bisogni-delle-persone-durante-la-pandemia-idA16 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Una-forma-atipica-di-osteogenesi-imperfetta-la-tipo-V-idA18 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Sindromi-da-iperaccrescimento-idA19 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Tafamidis-una-speranza-di-cura-per-i-pazienti-affetti-da-amiloidosi-cardiaca-da-transtiretina-wild-type-ed-ereditaria-idA20 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/La-cura-dei-tumori-rari-nellambito-della-Rete-Nazionale-Tumori-Rari-e-delle-Reti-di-Riferimento-Europee-idA22 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/pages/rivista/Attivita-sociali-FFC-Onlus-limpegno-di-volontari-e-donatori-per-sostenere-la-ricerca-idA23 0.40 2026-07-28T14:42:23+02:00 https://www.malattierare.eu/download/2020_2/MR_2_2020.pdf 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Amiloidosi-ereditaria-da-transtiretina-diagnosi-precoce-e-avanzamenti-terapeutici-idA25 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Bassa-statura-e-sindromi-rare-le-displasie-scheletriche-idA26 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Quale-ruolo-del-genetista-clinico-nellera-della-nuova-genomica-idA27 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Pioderma-gangrenoso-idA28 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-di-Gorham-Stout-patologia-complessa-e-assai-rara-di-tipo-proliferativo-vascolare-idA29 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-di-Ehlers-Danlos-un-dedalo-da-chiarire-idA30 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Volanesorsen-oligonucleotide-antisenso-per-la-sindrome-da-chilomicronemia-familiare-idA31 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Somministrazione-domiciliare-della-terapia-enzimatica-sostitutiva-idA32 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Esperienza-clinica-nelluso-di-una-terapia-orale-di-prima-linea-nei-pazienti-con-malattia-di-Gaucher-di-tipo-1-idA33 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Malattia-di-Wilson-dal-vissuto-clinico-del-paziente-la-fotografia-dei-bisogni-in-termini-di-diagnosi-e-terapia-idA34 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/FFC-Onlus-come-la-ricerca-puo-cambiare-una-malattia-genetica-considerata-senza-speranza-idA35 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/download/2020_1/MR_1_2020.pdf 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Pazienti-Undiagnosed-in-Italia-una-ricognizione-dei-progetti-in-corso-idA37 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Bassa-statura-e-sindromi-rare-idA38 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Le-malattie-rare-senza-diagnosi-iniziative-e-prospettive-idA39 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Lalfa-Mannosidosi-diagnosi-terapia-e-follow-up-idA40 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Pemfigoide-delle-membrane-mucose-idA41 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Una-condizione-ultra-rara-da-scoprire-la-sindrome-di-Kleefstra-idA42 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Laccesso-ai-farmaci-per-MR-lesperienza-di-Regione-Lombardia-idA43 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Malattie-rare-non-diagnosticate-idA44 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/EURORDIS-Rare-Diseases-Europe-la-voce-dei-malati-rari-e-dei-loro-familiari-in-Europa-idA45 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2019 0.60 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/download/2019_3/MR_3_2019.pdf 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Sindrome-di-Williams-transizione-dalleta-pediatrica-alleta-adulta-idA48 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Giovani-e-patologie-rare-quali-strategie-di-engagement-idA49 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Esordio-acuto-con-coma-iperammoniemico-nei-difetti-del-ciclo-dellurea-ad-esordio-tardivo-idA51 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Terapie-innovative-nellipercolesterolemia-familiare-omozigote-idA53 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Il-costo-insostenibile-dei-farmaci-orfani-che-fare-idA55 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/MetabERN-la-rete-di-riferimento-europea-per-le-malattie-metaboliche-ereditarie-idA56 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/download/2019_2/MR_2_2019.pdf 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Novita-terapeutiche-per-lemofilia-idA59 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Beckwith-Wiedemann-idA61 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Lynch-raccontata-dalla-Associazione-AIFEG-idA60 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-formazione-dellinfermiere-e-le-persone-con-malattie-rare-idA62 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-sclerosi-tuberosa-idA63 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-colangite-sclerosante-primitiva-idA64 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Smith-Magenis-fenotipo-comportamentale-e-profilo-metabolico-idA65 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Uso-off-label-dei-farmaci-nelle-malattie-rare-aspetti-normativi-e-organizzativi-idA66 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Novita-in-tema-di-alfa-Mannosidosi-idA67 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/download/2019_1/MR_1_2019.pdf 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/I-difetti-congeniti-del-metabolismo-intracellulare-della-vitamina-B12-idA69 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Resistenza-alla-deriva-antiscientifica-idA70 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Epilessia-correlata-a-PCDH19-e-sindrome-di-Dravet-fenotipi-clinici-e-strategie-terapeutiche-idA71 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Diagnosi-di-febbre-mediterranea-familiare-in-due-pazienti-affette-da-amiloidosi-AA-idA72 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Displasia-Fronto-Metafisaria-variabilita-fenotipica-ed-eterogeneita-genetica-idA73 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Utilizzo-di-nuove-tecnologie-per-lo-screening-allargato-idA74 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Le-Reti-in-Rete-idA75 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-somministrazione-a-domicilio-dei-farmaci-idA76 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Utilita-di-un-sistema-integrato-di-registrazione-delle-malattie-rare-su-base-regionale-lesperienza-della-Regione-Friuli-Venezia-Giulia-idA77 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2018 0.60 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/download/2018_3/MR_3_2018.pdf 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Latresia-congenita-digiuno-ileale-complessa-nuove-possibilita-di-trattamento-idA94 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-valutazione-psicologica-nelle-malattie-rare-complesse-idA95 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-crioglobulinemia-mista-HCV-correlata-dalla-diagnosi-alla-terapia-idA96 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/La-mastocitosi-sistemica-idA97 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Acondroplasia-e-se-fossimo-ad-un-passo-dal-cambiarne-la-storia-naturale-idA98 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Il-ruolo-dellinfermiere-di-ricerca-negli-studi-sulle-malattie-rare-idA99 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Nuove-opportunita-terapeutiche-per-lamiloidosi-ereditaria-da-transtiretina-idA100 0.40 2026-07-28T14:42:24+02:00 https://www.malattierare.eu/pages/rivista/Regione-Lombardia---Rete-regionale-per-le-malattie-rare-idA101 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/La-terapia-chaperonica-nuova-frontiera-nelle-malattie-lisosomiali-lesempio-del-migalastat-nella-malattia-di-Fabry-idA102 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/download/2018_2/MR_2_2018.pdf 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/Reticoloistiocitosi-lago-nel-pagliaio-talvolta-punge-idA104 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/La-neurofibromatosi-tipo-1-una-sindrome-da-predisposizione-ai-tumori-idA105 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/Screening-neonatale-esteso-delle-malattie-rare-e-prevenzione-di-una-carenza-vitaminica-idA106 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/Colestasi-intraepatiche-progressive-familiari-idA107 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/Citopenie-immuno-mediate-e-sindrome-di-Kabuki-idA108 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/Quando-un-WES-puo-indirizzare-la-clinica-un-paziente-con-sindrome-di-Rubinstein-Taybi-idA109 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/Malattie-da-accumulo-lisosomiale-nuove-prospettive-terapeutiche-grazie-a-CRISPRCas9-idA110 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/Dieta-vegana-e-carenze-nutrizionali-idA111 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/download/2018_1/MR_1_2018.pdf 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/LAgenzia-Italiana-del-Farmaco-per-le-Malattie-Rare-idA113 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/Farmaci-orfani-non-si-puo-attendere-idA114 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/Infezioni-respiratorie-ricorrenti-quando-sospettare-la-discinesia-ciliare-primaria-PCD-quale-il-percorso-diagnostico-idA118 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rivista/archivio-malattie-rare-anno-y2017 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/download/2017_3/MR_3_2017.pdf 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/download/2017_2/MR_2_2017.pdf 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/download/2017_1/MR_1_2017.pdf 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/supplementi/ 0.80 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/download/2023_3/s_MR_3_2023.pdf 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/download/2021_1/s_MR_1_2021.pdf 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/download/2017_2/s_MR_2_2017.pdf 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rareDiseaseDay/2024.php 0.80 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rareDiseaseDay/2026.php 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rareDiseaseDay/2021.php 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rareDiseaseDay/2020.php 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/rareDiseaseDay/2019.php 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/ 0.80 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Women-in-Rare-il-Libro-Bianco-sul-ritardo-diagnostico-idN361 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Leigh-una-scoperta-apre-la-strada-a-possibili-terapie-idN360 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Rett-uno-studio-indica-nuove-strade-per-la-terapia-genica-idN359 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Malattie-senza-diagnosi-il-programma-Telethon-cambia-il-destino-di-centinaia-di-famiglie-idN358 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Atassia-di-Friedreich-i-livelli-di-fratassina-nel-sangue-predicono-la-progressione-della-malattia-idN357 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Elevati-livelli-sierici-di-IL-18-allesordio-della-malattia-di-Still-correlazione-con-il-decorso-clinico-e-il-rischio-di-MAS-idN356 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Scoperto-un-nuovo-meccanismo-molecolare-alla-base-della-sindrome-NEDAMSS-idN355 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/AIFA-via-libera-alla-rimborsabilit-per-4-nuovi-farmaci-idN354 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Acondroplasia-il-10-aprile-a-Milano-il-Congresso-Beyond-Height-idN353 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/HHT-lo-studio-che-raddoppia-le-stime-di-prevalenza-idN352 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Malattia-di-Fabry-parere-positivo-del-CHMP-per-pegunigalsidasi-alfa-ogni-quattro-settimane-idN351 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Plasma-nel-2025-raccolte-quasi-920-tonnellate-idN349 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Carcinoma-squamoso-del-canale-anale-parere-positivo-CHMP-per-retifanlimab-in-prima-linea-idN350 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Alagille-ok-AIFA-alla-rimborsabilit-di-odevixibat-idN348 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Terapia-genica-per-SMARD1-uno-studio-apre-la-strada-a-cure-pi-sicure-ed-efficaci-idN345 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Emofilia-A-AIFA-approva-efanesoctocog-alfa-idN346 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Emofilia-A-parere-positivo-del-CHMP-per-efanesoctocog-alfa-una-volta-alla-settimana-idN237 0.40 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Bardet-Biedl-screening-diagnosi-e-follow-up-idN343 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Febbri-ricorrenti-nei-bambini-nuovi-criteri-clinici-per-riconoscere-le-forme-autoinfiammatorie-senza-diagnosi-genetica-idN344 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/archivio-news-anno-y2026 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/archivio-news-anno-y2025 0.60 2026-07-28T14:42:25+02:00 https://www.malattierare.eu/pages/news/Nuove-prospettive-terapeutiche-per-la-retinite-pigmentosa-idN341 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/FDA-approva-la-terapia-genica-per-la-sindrome-di-Wiskott-Aldrich-idN342 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Terapia-genica-neonatale-nuova-frontiera-per-la-mucopolisaccaridosi-di-tipo-I-idN340 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/EU-Biotech-Act-unopportunit-storica-per-le-malattie-rare-idN339 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Meeting-Nazionale-delle-Famiglie-2025-20-anni-di-impegno-contro-la-Niemann-Pick-idN338 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Exa-cel-accordo-di-rimborso-in-Italia-per-la-terapia-genica-in-beta-talassemia-e-anemia-falciforme-idN336 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Ipercolesterolemia-familiare-omozigote-ok-AIFA-ad-evinacumab-a-partire-dai-sei-mesi-di-vita-idN337 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Talassemia-un-farmaco-orale-apre-nuove-prospettive-terapeutiche-idN335 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/SMA-identificate-varianti-genetiche-rare-in-pazienti-affetti-dalla-patologia-idN334 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Mutazioni-nei-geni-COL4A1-A2-nuove-linee-guida-per-diagnosi-e-gestione-clinica-idN333 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/IDEA4RC-un-ecosistema-digitale-per-dare-forza-ai-dati-sui-tumori-rari-idN331 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Zorevunersen-il-farmaco-che-potrebbe-cambiare-la-storia-della-sindrome-di-Dravet-idN332 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Distrofia-di-Duchenne-nuove-evidenze-sulle-comorbidit-gravi-e-sul-ruolo-fondamentale-del-follow-up-a-lungo-termine-idN330 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Molgramostim-inalatorio-nuova-opzione-terapeutica-per-la-proteinosi-alveolare-polmonare-autoimmune-idN329 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/SAVI-chiarito-il-meccanismo-infiammatorio-alla-base-della-malattia-rara-idN328 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Fibrosi-cistica-scoperta-la-via-per-riportare-indietro-le-lancette-dellet-biologica-idN325 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Cannabidiolo-contro-lencefalopatia-epilettica-uno-studio-dimostra-efficacia-e-aumento-della-sopravvivenza-in-modello-murino-idN326 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Usher-primi-dati-promettenti-da-nuova-terapia-genica-idN327 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Emofilia-B-AIFA-approva-la-rimborsabilit-della-terapia-genica-idN324 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Terapia-genica-prenatale-un-modello-innovativo-per-intervenire-prima-della-nascita-idN323 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Donazione-mitocondriale-nuove-prospettive-nella-assistenza-riproduttiva-per-le-malattie-da-DNA-mitocondriale-idN322 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/CPVT-la-FDA-approva-studi-clinici-sulluomo-idN320 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Belimumab-estensione-dellindicazione-per-il-trattamento-del-LES-pediatrico-idN321 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Scoperta-una-nuova-mutazione-del-gene-LMNA-rischio-di-cardiomiopatia-e-morte-improvvisa-idN319 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Artrite-idiopatica-giovanile-a-esordio-sistemico-scoperti-i-difetti-silenziosi-del-sistema-immunitario-idN318 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Presentato-lXI-Rapporto-MonitoRare-UNIAMO-idN317 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Malattie-metaboliche-ereditarie-la-transizione-dallet-pediatrica-a-quella-adulta-in-Italia--ancora-un-percorso-a-ostacoli-idN315 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Fenilchetonuria-uno-studio-rivela-nuove-correlazioni-tra-genotipo-e-fenotipo-idN316 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Gli-effetti-dello-stress-e-lefficacia-delle-terapie-cellulari-per-la-cura-della-SLA-idN314 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Distrofia-di-Duchenne-AIFA-autorizza-limportazione-temporanea-di-ataluren-idN313 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-aggiornamento-dei-PDTA-idN312 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Fenilchetonuria-parere-positivo-del-CHMP-per-sepiapterina-idN311 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Arterite-a-cellule-giganti-ok-a-upadacitinib-in-Europa-idN310 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Leucodistrofia-metacromatica-la-somministrazione-precoce-della-terapia-genica-pu-cambiare-la-storia-della-malattia-idN309 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/AIFA-approva-il-bando-di-ricerca-indipendente-2025-sulle-malattie-rare-idN307 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Terapia-genica-per-la-SMA-risultati-promettenti-dagli-studi-di-fase-3-idN308 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Phelan-McDermid-comprenderla-per-sviluppare-nuovi-approcci-terapeutici-idN305 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Scoperti-tramite-lediting-genetico-i-meccanismi-alla-base-della-sindrome-VEXAS-idN306 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Fenilchetonuria-linee-guida-per-la-diagnosi-e-presa-in-carico-basate-sulla-revisione-sistematica-del-2023-dellACMG-idN304 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Screening-per-la-leucodistrofia-metacromatica-in-Lombardia-idN303 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Spina-bifida-un-aumento-della-frequenza-di-variazioni-del-DNA-pu-contribuire-al-28-di-rischio-di-malattia-idN302 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Setacciare-lintero-genoma-alla-ricerca-delle-cause-delle-malattie-rare-il-progetto-GENRARE-idN301 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Rett-lUniversit-di-Trieste-coordiner-la-prima-sperimentazione-al-mondo-con-mirtazapina-idN300 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Giuseppe-Remuzzi-nella-Lancet-Commission-on-Rare-Diseases-idN299 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Colangite-biliare-primitiva-dalla-CE-via-libera-a-seladelpar-idN298 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Epilessia-gelastica-a-Verona-primo-caso-trattato-con-metodica-MRgFUS-idN297 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/SMA-i-neonati-potranno-essere-trattati-con-risdiplam-fin-dalla-nascita-idN295 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Parere-positivo-del-CHMP-di-EMA-per-lallargamento-alluso-di-ivacaftortezacaftorelexacaftor-in-Europa-idN296 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Glomerulopatia-da-C3-parere-positivo-del-CHMP-per-iptacopan-idN294 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/LUnione-europea-approva-acoramidis-per-pazienti-adulti-con-amiloidosi-da-transtiretina-e-cardiomiopatia-idN293 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/RealiseD-il-progetto-per-cambiare-il-paradigma-degli-studi-clinici-nelle-malattie-rare-e-ultra-rare-idN291 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Malattie-rare-e-disabilit-complesse-in-et-pediatrica-per-i-neuropsichiatri-infantili--prioritario-garantire-la-continuit-di-cura-idN292 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Colangite-biliare-primitiva-autorizzazione-europea-condizionata-per-seladelpar-idN290 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/La-ri-analisi-genetica-produce-500-nuove-diagnosi-di-malattie-rare-in-Europa-idN289 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Odevixibat-per-il-trattamento-della-colestasi-intraepatica-familiare-idN288 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Inebilizumab-il-primo-farmaco-sicuro-ed-efficace-per-la-malattia-IgG4-correlata-idN287 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/archivio-news-anno-y2024 0.60 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Epidermolisi-bollosa-distrofica-recessiva-una-speranza-di-cura-con-il-trapianto-di-pelle-geneticamente-modificata-idN286 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Rett-al-via-la-raccolta-di-video-per-addestrare-lIA-a-riconoscere-la-malattia-idN285 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/SLA-identificata-una-nuova-potenziale-terapia-per-la-forma-legata-a-mutazioni-del-gene-C9orf72-idN283 0.40 2026-07-28T14:42:26+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Sanfilippo-pinzette-molecolari-arrestano-la-neurodegenerazione-e-potenziano-leffetto-della-terapia-genica-idN284 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Malattia-di-Fabry-AIFA-approva-pegunigalsidasi-alfa-idN282 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Ipercolesterolemia-familiare-comprendere-i-rischi-genetici-per-migliorare-la-salute-cardiovascolare-idN281 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/BeACH-un-progetto-di-cura-unico-per-unalleanza-terapeutica-innovativa-in-bambini-con-acondroplasia-idN280 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/ERDERA-progetto-per-il-coordinamento-della-ricerca-in-Europa-sulle-malattie-rare-idN279 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Leigh-al-via-lo-sviluppo-di-una-terapia-farmacologica-neonatale-e-di-una-terapia-genica-fetale-in-utero-idN278 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Colangite-biliare-primitiva-approvazione-accelerata-per-seladelpar-idN277 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Ipercolesterolemia-familiare-eterozigote-dati-positivi-per-obicetrapib-idN276 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Dalla-stimolazione-cerebrale-non-invasiva-una-speranza-per-rallentare-la-SLA-idN275 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Malattie-genetiche-maggiore--let-del-padre-pi-alto--il-rischio-per-il-nascituro-idN274 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Alagille-parere-positivo-del-Chmp-per-odevixibat-contro-il-prurito-idN272 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Porpora-trombotica-trombocitopenica-congenita-la-Commissione-europea-approva-la-prima-terapia-enzimatica-sostitutiva-idN273 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Atassia-di-Friedreich-al-Medea-di-Brindisi-la-prima-terapia-con-omaveloxolone-appena-approvato-dallAIFA-idN269 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Progetto-SATURN-lutilizzo-dei-dati-per-favorire-laccesso-alle-nuove-terapie-idN270 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Colangite-biliare-positiva-parere-positivo-per-elafibranor-idN271 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Fabrys-Kitchen-un-ricettario-per-alleviare-i-sintomi-della-malattia-di-Anderson-Fabry-idN267 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Lodissea-diagnostica-dei-malati-rari-i-risultati-di-una-survey-EURORDIS-idN268 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Angelini-Pharma-e-Mario-Negri-collaborazione-di-ricerca-per-identificare-nuovi-target-terapeutici-in-epilessia-idN266 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Malattie-colestatiche-rare-parere-positivo-del-CHMP-su-elafibranor-nella-colangite-biliare-primitiva-e-su-odevixibat-per-la-sindrome-di-Alagille-idN264 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Shine-a-light-on-XLH-la-campagna-che-accende-i-riflettori-sullipofosfatemia-legata-alla-X-idN265 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Distrofia-muscolare-di-Duchenne-una-nuova-strategia-per-favorire-la-riparazione-e-la-rigenerazione-dei-tessuti-idN263 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/SLA-nuove-prospettive-terapeutiche-da-una-molecola-in-sperimentazione-contro-la-leucemia-idN262 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Al-Gaslini-salvata-piccola-paziente-inglese-affetta-da-una-patologia-rarissima-al-cuore-idN259 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Colangite-biliare-primitiva-nuovi-dati-di-efficacia-a-lungo-termine-di-elafibranor-idN261 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/SLA-il-riutilizzo-di-farmaci-incentiva-lavvio-di-nuove-strategie-terapeutiche-idN258 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Durvalumab-con-chemioterapia-aumenta-la-sopravvivenza-globale-nei-pazienti-con-tumori-delle-vie-biliari-idN260 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/IRDiRC-implementazione-della-genomica-nello-screening-neonatale-per-le-malattie-metaboliche-ereditarie-idN256 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Lo-stigma-nelle-malattie-rare-idN257 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Lombardia-al-via-il-progetto-per-lo-screening-neonatale-della-leucodistrofia-metacromatica-idN255 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Fibrosi-cistica-finanziata-ricerca-del-Gaslini-per-nuove-terapie-idN254 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Malattia-di-Huntington-scoperte-nuove-informazioni-sulle-molecole-circolari-non-codificanti-idN253 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Exa-cel-i-dati-a-lungo-termine-evidenziano-un-beneficio-duraturo-nel-trattamento-di-anemia-falciforme-e-talassemia-idN251 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/JARDIN-la-nuova-azione-congiunta-a-supporto-dellintegrazione-delle-ERN-idN252 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Distrofia-di-Duchenne-la-Commissione-Europea-chiede-di-rivalutare-ataluren-idN250 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/PKUnoi-sabato-29-giugno-levento-online-idN249 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Turner-lapproccio-multidisciplinare-per-una-crescita-armonica-a-tutela-dalle-complicanze-associate-idN247 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Le-red-flag-delle-malattie-rare-un-approccio-basato-sulle-esperienze-dei-pazienti-idN248 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Studio-del-Mario-Negri-rivela-i-bisogni-e-le-priorit-dei-pazienti-con-SLA-idN246 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Passi-avanti-nella-ricerca-di-base-sulla-sindrome-di-Down-idN244 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Carcinoma-anaplastico-della-tiroide-identificata-nuova-possibile-terapia-idN245 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Neurofibromatosi-1-una-campagna-per-spiegare-ai-bambini-di-elementari-e-medie-la-malattia-insegnando-inclusione-e-rispetto-delle-diversit-idN243 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Glomerulosclerosi-focale-segmentale-ricorrente-post-trapianto-efficacia-del-trattamento-combinato-con-rituximab-e-daratumumab-idN242 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Paraplegia-spastica-ereditaria-nuove-prospettive-terapeutiche-idN241 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/EPN-pegcetacoplan-approvato-in-Europa-per-luso-in-pazienti-adulti-naive-al-trattamento-idN240 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Editing-del-genoma-guariti-da-talassemia-e-anemia-falciforme-grazie-alle-forbici-molecolari-idN239 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Dal-microbioma-nuove-tecnologie-per-le-malattie-genetiche-idN238 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Effetti-neuroprotettivi-di-niclosamide-in-modelli-SLA-idN236 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Effetti-a-breve-termine-della-PEP-mask-sulla-disomogeneit-della-ventilazione-nei-bambini-con-fibrosi-cistica-idN235 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Un-programma-di-telemedicina-per-migliorare-le-abilit-sociali-degli-adolescenti-con-neurofibromatosi-tipo-1-idN234 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Colangite-biliare-primitiva-in-arrivo-due-nuovi-farmaci-idN233 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Maralixibat-approvazione-della-FDA-per-il-trattamento-del-prurito-colestatico-nei-pazienti-con-colestasi-intraepatica-familiare-progressiva-idN232 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/RINGS-studio-sullimpatto-dello-screening-genomico-neonatale-i-risultati-idN231 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Iptacopan-parere-positivo-dal-CHMP-come-prima-monoterapia-orale-per-pazienti-adulti-con-emoglobinuria-parossistica-notturna-idN230 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Distrofia-muscolare-di-Duchenne-lFDA-approva-givinostat-per-il-trattamento-per-via-orale-di-pazienti-di-et-pari-o-superiore-a-6-anni-idN229 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Nuovo-studio-su-ipogonadismo-ipogonadonatropo-congenito-in-pazienti-maschi-idN228 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Un-organoide-di-osso-per-lo-studio-delle-malattie-genetiche-rare-idN227 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Lynch-identificazione-delle-lesioni-precancerose-del-colon-retto-mediante-biopsia-liquida-idN226 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/NF1-LAgenzia-Italiana-del-Farmaco-AIFA-ha-approvato-la-rimborsabilit-di-selumetinib-idN225 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/SLA-aperto-il-Bando-AriSLA-2024-per-progetti-di-ricerca-idN223 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Scoperta-nuova-malattia-del-neurosviluppo-associata-a-una-mutazione-del-gene-DENND5B-idN224 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/LIstituto-Mario-Negri-nella-Rete-per-le-malattie-rare-non-diagnosticate-idN220 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Wiskott-Aldrich-Fondazione-Telethon-si-impegna-a-rendere-disponibile-la-terapia-genica-idN221 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/ADA-SCID-il-farmaco-per-la-terapia-genica-sar-prodotto-e-distribuito-da-Telethon-idN208 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/ADA-SCID-positivi-i-risultati-a-lungo-termine-per-la-terapia-genica-idN219 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Duchenne-le-associazioni-chiedono-il-rinnovo-dellautorizzazione-per-ataluren-idN218 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-celebra-la-Giornata-Mondiale-delle-Malattie-Rare-2024-idN217 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Mielofibrosi-via-libera-della-Commissione-Europea-a-momelotinib-idN216 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Medulloblastoma-indentificato-nuovo-bersaglio-per-il-trattamento-del-tumore-cerebrale-pediatrico-idN214 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Terapia-con-cellule-CAR-T-al-Bambino-Ges-trattati-i-primi-tre-pazienti-con-malattia-autoimmune-idN215 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/archivio-news-anno-y2023 0.60 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Anemia-di-Fanconi-scoperta-la-firma-molecolare-idN213 0.40 2026-07-28T14:42:27+02:00 https://www.malattierare.eu/pages/news/Oneri-per-la-cura-delle-malattie-rare-e-loro-impatto-economico-per-i-cittadini-europei-il-rapporto-di-Chiesi-Global-Rare-Diseases-idN212 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Emapalumab-farmaco-salvavita-per-la-sindrome-da-attivazione-macrofagica-idN211 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Deficit-di-GH-la-terapia-con-lormone-della-crescita-passa-da-una-somministrazione-giornaliera-a-una-settimanale-idN210 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Dire-fare-comuniCARE-idN209 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Lombardia-screening-neonatale-per-la-SMA-idN207 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Un-vademecum-per-la-gestione-della-sindrome-nefrosica-idN205 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/FFC-Ricerca-lancia-una-campagna-di-sensibilizzazione-sul-test-del-portatore-di-fibrosi-cistica-e-finanzia-progetti-scientifici-e-borse-di-studio-per-trovare-una-idN206 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/SMA-la-Commissione-Europea-approva-risdiplam-per-i-bambini-sotto-i-due-mesi-di-vita-idN204 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Malattie-neurodegenerative-rare-individuata-una-molecola-in-grado-di-debellare-i-prioni-bloccandone-la-replicazione-idN203 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Manibl-la-graphic-novel-dedicata-alla-sclerodermia-idN202 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Miastenia-gravis-efgartigimod-alfa-rimborsabile-anche-in-Italia-idN201 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Nuova-strategia-genetica-per-contrastare-la-malattia-di-Huntington-idN200 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Colangite-biliare-primitiva-annunciati-i-risultati-positivi-dello-studio-di-Fase-III-ELATIVE-su-elafibranor-idN199 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Ricerca-sulle-distonie-un-prestigioso-riconoscimento-al-team-del-Policlinico-di-Milano-idN198 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Fondazione-Aiuti-per-la-Ricerca-sulle-Malattie-Rare-bando-di-concorso-ARMR-2024-idN197 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Diventa-anche-tu-figo-inizia-a-donare-idN196 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Williams-unapp-per-affrontare-lansia-idN194 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Malattie-rare-senza-diagnosi-pubblicata-la-Carta-per-il-riconoscimento-dei-diritti-dei-pazienti-idN195 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/ERN-EuroBloodNet-collaborazione-per-superare-le-difficolta-nella-ricerca-sullanemia-a-cellule-falciformi-idN193 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Acondroplasia-nuove-informazioni-sul-burden-of-disease-idN192 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Sindrome-dellX-Fragile-scoperto-un-nuovo-meccanismo-molecolare-possibile-bersaglio-terapeutico-idN191 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Impatto-dellintelligenza-artificiale-nella-cura-e-nello-studio-delle-malattie-rare-idN190 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Nuove-prospettive-per-la-correzione-genetica-nella-sindrome-ICF-idN189 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Bambino-Gesu-scoperta-una-nuova-malattia-genetica-mascherata-da-allergia-idN188 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Ipofosfatemia-X-linked-burosumab-disponibile-in-Italia-anche-per-i-pazienti-adulti-idN187 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Giornata-Mondiale-dei-difetti-congeniti-supplementazione-con-acido-folico-nel-periodo-periconcezionale-e-programmi-di-screening-idN186 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Al-Bambino-Gesu-un-percorso-dedicato-alla-sindrome-di-Kabuki-idN185 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Approvato-il-Piano-Nazionale-Malattie-Rare-2023-2025-idN184 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Il-Paese-delle-Rarita-le-malattie-rare-diventano-un-fumetto-idN183 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-celebra-la-Giornata-Mondiale-delle-Malattie-Rare-idN182 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Rapporto-ISTISAN-sullo-Screening-neonatale-esteso-idN181 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Malattia-di-Kennedy-nuove-evidenze-sui-meccanismi-molecolari-alla-base-della-malattia-idN180 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-aggiorna-i-PDTA-e-pubblica-i-documenti-relativi-alle-glomerulopatie-primitive-idN179 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Rett-lintelligenza-artificiale-per-una-diagnosi-precoce-idN176 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Rare-Disease-Moonshoot-liniziativa-che-accelera-la-ricerca-sulle-malattie-piu-rare-idN177 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/26-Convegno-Patologia-Immune-e-Malattie-Orfane-idN178 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Nuova-luce-per-la-cura-della-distrofia-muscolare-di-Duchenne-idN175 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/La-Commissione-Europea-concede-lapprovazione-a-tabelecleucel-idN174 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/archivio-news-anno-y2022 0.60 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Smith-Magenis-identificati-i-meccanismi-patologici-implicati-nella-malattia-genetica-rara-idN172 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/FDA-approva-la-prima-terapia-genica-per-lemofilia-B-idN173 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Malattia-di-Castleman-individuato-un-sottotipo-specifico-che-risponde-a-trattamenti-mirati-idN171 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Atrofia-muscolare-spinale-di-tipo-1-prima-terapia-genica-in-Friuli-Venezia-Giulia-idN170 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/App-per-malattie-rare-una-valutazione-qualitativa-idN168 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Mutazioni-in-LTV1-e-sindrome-LIPHAK-idN169 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/19-Ottobre-IV-Giornata-Internazionale-della-Malattia-di-Niemann-Pick-idN166 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Lettera-aperta-della-comunita-dei-pazienti-alla-Commissione-Europea-per-una-nuova-strategia-sulle-malattie-rare-idN167 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Eculizumab-approvato-in-Italia-per-il-disturbo-dello-spettro-della-neuromielite-ottica-e-per-la-miastenia-gravis-generalizzata-idN165 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Malattie-rare-quanto-ne-sanno-i-medici-idN164 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Fibrosi-cistica-ivacaftortezacaftorelexacaftor-in-associazione-con-ivacaftor-rimborsabile-anche-per-la-fascia-di-eta-6-11-anni-idN163 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Mutazioni-in-NPTX1-causano-lo-stress-del-reticolo-endoplasmatico-e-atassia-cerebellare-autosomica-dominante-idN161 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Deficit-di-CDKL5-unindagine-per-individuare-i-bisogni-sanitari-e-assistenziali-dei-pazienti-idN162 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Elezioni-2022-appello-di-UNIAMO-per-una-politica-a-favore-dei-malati-rari-idN160 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Epidermolisi-bollosa-semplice-esiti-riportati-dai-pazienti-e-burden-of-disease-idN158 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Acondroplasia-AIFA-autorizza-vosoritide-idN159 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Malan-pubblicate-le-prime-linee-guida-idN157 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Elexacaftortezacaftorivacaftor-nei-bambini-tra-i-6-e-gli-11-anni-con-fibrosi-cistica-eterozigote-per-F508del-e-una-mutazione-a-funzione-minima-idN156 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Leigh-dai-vettori-virali-adeno-associati-possibili-nuove-cure-per-le-malattie-mitocondriali-idN155 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Ruolo-del-sistema-immunitario-nella-diagnosi-e-nel-trattamento-della-SLA-giovanile-idN154 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Fattori-associati-a-forme-severe-di-COVID-19-in-persone-con-fibrosi-cistica-idN153 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Malattia-di-Huntington-a-esordio-tardivo-caratteristiche-cliniche-e-genetiche-idN152 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Citizen-science-cittadini-e-istituzioni-insieme-per-condividere-idee-e-progetti-al-servizio-delle-persone-con-malattia-rara-idN151 0.40 2026-07-28T14:42:28+02:00 https://www.malattierare.eu/pages/news/Fondazione-Aiuti-per-la-Ricerca-sulle-Malattie-Rare-bando-di-concorso-ARMR-2023-idN150 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Fattori-associati-a-forme-severe-di-infezione-da-SARS-CoV-2-in-persone-con-fibrosi-cistica-idN149 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Angelman-la-ricerca-Cnr-per-migliorarne-la-terapia-idN148 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Colangiocarcinoma-ok-Aifa-a-pemigatinib-idN147 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Mucopolisaccaridosi-tipo-6-risultati-positivi-dalla-terapia-genica-idN146 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Un-nuovo-protocollo-di-terapia-genica-con-cellule-staminali-sfrutta-la-tecnologia-mRNA-per-evitare-la-somministrazione-di-chemioterapia-idN145 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/MetabERN-Screen4rare-per-i-programmi-europei-di-screening-neonatale-idN144 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Ipertensione-arteriosa-polmonare-dagli-anticorpi-monoclonali-contro-EMAP-II-un-potenziale-trattamento-in-grado-di-modificare-la-malattia-idN143 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Nasce-io-RARO-lAssociazione-a-supporto-dei-malati-di-tumori-rari-e-delle-loro-famiglie-idN142 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Scoperta-una-nuova-malattia-ultrarara-la-sindrome-cardio-facio-cutaneo-articolare-idN140 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Atassie-pediatriche-online-le-Linee-guida-idN141 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/ModelMatcher-la-piattaforma-online-che-favorisce-le-collaborazioni-nel-campo-della-ricerca-idN139 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Emofilia-B-lEMA-inizia-la-revisione-della-terapia-genica-etranacogene-dezaparvovec-idN137 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Deficit-di-Alfa1-Antitripsina-un-algoritmo-per-la-gestione-del-paziente-idN138 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Malattia-di-Lyme-un-report-mostra-bisogni-di-pazienti-e-caregiver-idN136 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Fibrosi-cistica-AIFA-estende-la-rimborsabilita-di-elexacaftortezacaftorivacaftor-in-associazione-con-ivacaftor-ai-pazienti-con-almeno-una-mutazione-F508del-idN135 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-aggiorna-i-PDTA-pubblicando-i-documenti-relativi-alla-ipertensione-polmonare-arteriosa-idiopatica-idN134 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Una-terapia-cellulare-per-la-distrofia-muscolare-di-Duchenne-idN133 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/MetabERN-10-raccomandazioni-per-lo-screening-neonatale-idN132 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-aggiorna-i-PDTA-pubblicando-i-documenti-relativi-alla-sindrome-Emolitico-Uremica-idN131 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Identificati-i-difetti-molecolari-di-due-patologie-neurologiche-idN130 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Malattie-Metaboliche-Ereditarie-AISMME-aggiornamento-screening-e-cure-precoci-per-salvare-i-neonati-idN129 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Impatto-della-pandemia-COVID-19-sulle-patologie-reumatologiche-idN128 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Societa-Italiana-di-Pediatria-il-72-delle-malattie-rare-ha-origine-genetica-fondamentale-lo-screening-neonatale-idN127 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-aggiorna-i-PDTA-pubblicando-i-documenti-relativi-al-gruppo-Linfedemi-primari-cronici-idN126 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Peso-clinico-umano-ed-economico-dellemofilia-B-grave-negli-adulti-idN125 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Leucodistrofia-metacromatica-studio-dimostra-efficacia-e-sicurezza-della-terapia-genica-idN124 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/archivio-news-anno-y2021 0.60 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Cornelia-de-Lange-nuova-luce-sui-processi-molecolari-idN123 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Distrofia-miotonica-un-passo-avanti-verso-la-terapia-genica-idN122 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Distrofie-muscolari-dei-cingoli-nuovo-modello-animale-per-lo-studio-della-malattia-idN121 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Fibrosi-cistica-nuovi-modelli-cellulari-derivati-da-epitelio-nasale-per-saggiare-lefficacia-delle-terapie-del-difetto-di-base-anche-nei-confronti-di-rare-mutazi-idN120 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Terapia-genica-per-epidermolisi-bollosa-positivi-i-risultati-clinici-a-lungo-termine-idN119 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Tecnologie-a-sostegno-delle-disabilita-fragilita-e-malattie-rare-online-il-nuovo-sondaggio-idN117 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Funzioni-esecutive-e-qualita-della-vita-nei-bambini-con-neurofibromatosi-tipo-I-idN118 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Amaurosi-di-Leber-intervento-con-la-prima-terapia-genica-oculare-idN116 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/COVID-19-Regione-Lombardia-proroga-la-validita-dei-Piani-terapeutici-per-malattie-rare-idN115 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Hurler-primi-risultati-positivi-della-terapia-genica-idN114 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Testo-Unico-la-sintesi-idN113 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Sospensione-accesso-al-Fondo-nazionale-Aifa-5-idN112 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Ipogonadismo-ipogonadotropo-congenito-scoperte-mutazioni-a-carico-del-gene-PRDM13-idN111 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Crigler-Najjar-curate-con-la-terapia-genica-le-prime-tre-pazienti-al-mondo-idN109 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Il-punto-di-vista-dei-pazienti-ERN-a-confronto-il-30-novembre-2021-idN110 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Malattie-rare-il-Senato-approva-il-testo-unico-idN108 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Giornata-Mondiale-per-la-Sindrome-da-Ipoventilazione-Centrale-Congenita-idN107 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Che-la-forza-sia-con-noi-19-Ottobre-Giornata-Internazionale-della-malattia-di-Niemann-Pick-idN106 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Campagna-di-sensibilizzazione-per-la-Charcot-Marie-Tooth-idN105 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/SLA-nuove-prospettive-per-la-diagnosi-idN104 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/The-Broken-Doll-il-cartone-che-spiega-lHuntington-ai-bambini-idN103 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Sclerosi-sistemica-ok-AIFA-per-la-terapia-infusionale-domiciliare-con-iloprost-idN102 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/SAMMY-seq-la-tecnologia-per-sequenziare-il-DNA-e-studiare-linvecchiamento-precoce-idN101 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Duchenne-Parent-Project-Aps-scrive-ad-AIFA-per-laccesso-precoce-a-eteplirsen-idN100 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Al-via-la-campagna-Facciamo-rete-contro-i-sarcomi-idN98 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Malattie-parossistiche-rare-studio-getta-nuova-luce-sul-ruolo-del-gene-PRRT2-idN99 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Protocollo-dintesa-fra-OMS-e-Rare-Diseases-International-idN97 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Rapporto-MonitoRare-eccellenza-screening-neonatale-in-calo-lattivita-di-ricerca-idN96 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Malattia-di-Huntington-uno-studio-descrive-un-collegamento-tra-specifiche-alterazioni-del-comportamento-e-delle-capacita-cognitive-idN95 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Cardiomiopatia-amiloide-da-transtiretina-e-polineuropatia-amiloide-lesperienza-dei-pazienti-e-dei-loro-familiari-idN94 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Sostegno-psicologico-UNIAMO-avvia-un-progetto-pilota-idN93 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Fenilchetonuria-grazie-alla-telemedicina-miglioramenti-del-controllo-metabolico-e-del-rapporto-con-il-centro-di-riferimento-idN92 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Fibrosi-cistica-AIFA-approva-nuovi-farmaci-idN91 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Istituito-il-Tavolo-tecnico-in-tema-di-malattie-rare-idN90 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Linfoistiocitosi-emofagocitica-a-Pietro-Merli-il-Premio-RICERCA-OLTRE-LHLH-2021-idN89 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Nuove-possibilita-per-il-controllo-delle-cellule-staminali-nelle-terapie-avanzate-idN88 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Thalassemia-Day-nuovi-paradigmi-nella-gestione-delle-emoglobinopatie-idN87 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Emergenza-COVID-19-Regione-Lombardia-proroga-la-validita-dei-Piani-terapeutici-per-malattie-rare-idN86 0.40 2026-07-28T14:42:29+02:00 https://www.malattierare.eu/pages/news/Screening-neonatale-in-un-position-paper-gli-11-principi-chiave-di-EURORDIS-per-armonizzare-lapproccio-in-tutta-Europa-idN85 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Ben-Essere-un-percorso-di-virtual-coaching-per-le-persone-con-malattia-rara-idN84 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Kleine-Levin-varianti-genetiche-e-problemi-alla-nascita-tra-le-possibili-cause-idN83 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Dal-cromosoma-X-indicazioni-sulle-cause-della-colangite-biliare-primitiva-idN82 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Giornata-Mondiale-Malattie-Rare---Piemonte-e-Valle-dAosta-idN81 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/25-febbraio-Rare-Disease-Day-Lombardia-idN80 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Emergenza-COVID-19-Regione-Lombardia-proroga-i-termini-dei-Piani-terapeutici-per-malattie-rare-idN79 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/archivio-news-anno-y2020 0.60 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Un-percorso-di-gioco-per-bambini-con-patologie-metaboliche-per-facilitare-lapproccio-alle-terapie-infusive-idN78 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Prader-Willi-avviato-il-Registro-Nazionale-sulla-piattaforma-web-dellISS-dedicata-ai-Registri-di-patologia-rara-idN77 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Identificato-il-nuovo-gene-YIF1B-alla-base-di-un-grave-ritardo-del-neurosviluppo-idN76 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-aggiorna-i-PDTA-pubblicando-i-documenti-su-Sindrome-di-Rett-e-Istiocitosi-a-cellule-di-Langerhans-idN75 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Estesa-al-15-novembre-la-deadline-per-il-questionario-online-sullesperienza-delle-persone-fragili-nellera-COVID-19-idN74 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/19-Ottobre-Giornata-Mondiale-della-Niemann-Pick-idN73 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Ottobre-2020-Campagna-europea-di-sensibilizzazione-sulla-Charcot-Marie-Tooth-idN72 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Rapporto-ISS-su-malattia-di-Kawasaki-ed-infezione-da-SARS-CoV-2-idN70 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-aggiorna-i-PDTA-pubblicando-i-documenti-su-sclerosi-sistemica-progressiva-e-sclerosi-cutanea-diffusa-ad-alta-gravita-clinica-idN69 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/ARIA-progetto-per-bambini-con-sindrome-CHARGE-a-cui-il-COVID-19-ha-sottratto-servizi-essenziali-idN68 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/EURORDIS-una-survey-mostra-gli-effetti-della-pandemia-da-coronavirus-sulla-comunita-dei-malati-rari-idN67 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Il-29-giugno-si-celebra-la-Giornata-Mondiale-della-Sclerosi-Sistemica-idN66 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Emergenza-COVID-19-Regione-Lombardia-estende-validita-dei-piani-terapeutici-per-malattie-rare-idN65 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Emergenza-COVID-19-proroga-dei-piani-terapeutici-per-i-pazienti-con-malattie-rare-idN64 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Covid-19-il-vademecum-del-Comitato-scientifico-di-AIAF-sulle-terapie-idN63 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Emergenza-COVID-19-al-via-uno-studio-nazionale-per-conoscere-limpatto-del-lockdown-sui-bambini-con-problematiche-neuropsichiatriche-e-sulle-loro-famiglie-idN62 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Fisioterapia-online-ai-tempi-del-Coronavirus-ASAMSI-presenta-il-FisioTe-delle-1700-idN60 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/EURORDIS-ai-responsabili-politici-raccomandazioni-per-proteggere-le-persone-con-malattia-rara-durante-la-pandemia-di-COVID-19-idN61 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Coronavirus-Regione-Lombardia-proroga-i-piani-terapeutici-per-le-malattie-rare-idN59 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Coronavirus-e-bambini-con-disabilita-idN71 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/download/Simgeped_coronavirus_e_disabilita.pdf 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/SPAZI-RARI-al-via-i-percorsi-di-supporto-gratuito-a-distanza-per-persone-con-malattia-rara-familiari-e-caregiver-idN57 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Malattie-metaboliche-uno-studio-italiano-sperimenta-con-successo-limpiego-di-staminali-epatiche-idN58 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/archivio-news-anno-y2019 0.60 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Retinite-pigmentosa-con-mutazioni-del-gene-RPE65-miglioramento-della-capacita-visiva-grazie-ad-uninnovativa-terapia-genica-idN56 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/EURORDIS-Photo-Award-2020-ce-tempo-fino-al-16-gennaio-per-partecipare-al-concorso-fotografico-dedicato-alle-malattie-rare-idN55 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Malattie-genetiche-rare-diagnosi-piu-rapida-grazie-ad-una-nuova-piattaforma-tecnologica-idN54 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Malattie-rare-5-richieste-al-Ministro-della-Salute-da-parte-di-istituzioni-pazienti-e-tecnici-idN53 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/EURORDIS-amplificare-la-voce-dei-pazienti-nelle-ERN-idN52 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Nuovi-finanziamenti-alle-ERN-per-lo-sviluppo-di-registri-per-le-malattie-rare-idN50 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Accordo-tra-Fondazione-LIRH-ed-Ospedale-Bambino-Gesu-nasce-Spazio-Huntington-idN51 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Emoglobinuria-parossistica-notturna-approvazione-europea-per-ravulizumab-idN49 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/MonitoRare-presentato-il-V-rapporto-sulla-condizione-della-persona-con-malattia-rara-in-Italia-idN48 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/EURORDIS-chiede-assistenza-globale-entro-il-2030-per-i-30-milioni-di-malati-rari-europei-idN47 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Neuropatia-ottica-ereditaria-di-Leber-accordo-tra-Chiesi-e-Santhera-per-la-licenza-di-un-farmaco-orfano-idN46 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Lombardia-aggiornamento-della-Rete-Regionale-per-le-malattie-rare-idN45 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Emofilia-lappello-di-FedEmo-in-occasione-della-XV-Giornata-Mondiale-idN44 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Wiskott-Aldrich-studio-clinico-dimostra-lefficacia-della-terapia-genica-idN43 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Trapianto-del-cromosoma-approccio-futuro-alle-patologie-genomiche-oggi-incurabili-idN41 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/SLA-completato-latlante-dei-geni-coinvolti-idN42 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Il-punto-di-vista-del-paziente-circa-la-progettazione-degli-studi-clinici-sulle-malattie-rare-idN39 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Il-punto-di-vista-del-paziente-circa-la-progettazione-degli-studi-clinici-sulle-malattie-rare-idN40 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Fibrosi-cistica-da-un-antimicotico-un-possibile-trattamento-idN38 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/SLA-i-calciatori-di-serie-A-hanno-un-rischio-6-volte-maggiore-rispetto-alla-popolazione-generale-idN37 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Amiloidosi-cardiaca-svelata-la-struttura-molecolare-delle-fibre-di-amiloidi-idN35 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/La-terapia-nutrizionale-nella-gestione-del-rene-policistico-idN36 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Emofilia-A-la-Commissione-Europea-approva-emicizumab-anche-per-i-pazienti-senza-inibitori-idN34 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Terapia-genica-dellemofilia-B-AMT-061-entra-in-fase-III-idN33 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Emofilia-A-in-arrivo-un-nuovo-fattore-VIII-long-acting-idN32 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Primi-risultati-di-efficacia-e-sicurezza-per-la-terapia-genica-nella-beta-talassemia-idN31 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Regione-Lombardia-celebra-la-Giornata-Mondiale-delle-Malattie-Rare-idN29 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Colangite-biliare-primitiva-in-sperimentazione-un-nuovo-farmaco-contro-il-prurito-idN30 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Fibrosi-cistica-lumacaftorivacaftor-approvato-in-Europa-per-i-bambini-da-2-a-5-anni-idN25 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Descritta-la-sindrome-PERCHING-nuova-patologia-multisistemica-causata-da-anomalie-nel-gene-KLHL7-idN26 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Angioedema-ereditario-scoperto-un-nuovo-potenziale-bersaglio-terapeutico-idN27 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Pensavo-di-essere-diverso-il-documentario-sullunico-caso-europeo-di-XLPDR-idN28 0.40 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/archivio-news-anno-y2018 0.60 2026-07-28T14:42:30+02:00 https://www.malattierare.eu/pages/news/Leucemia-linfoblastica-acuta-Ph-pazienti-in-remissione-con-terapia-precoce-con-imatinib-idN23 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Sclerosi-multipla-fingolimod-approvato-in-Europa-per-bambini-e-adolescenti-idN24 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Fibrosi-cistica-approvazione-europea-per-tezacaftorivacaftor-in-associazione-con-ivacaftor-idN22 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Lombardia--ricerca-premiata-la-terapia-genica-ex-vivo-per-la-cura-dellepidermolisi-bollosa-idN21 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Research-to-Care-un-bando-per-sostenere-la-ricerca-scientifica-in-Italia-idN20 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Italia-quarta-in-Europa-per-accesso-ai-farmaci-per-le-malattie-rare-idN19 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Home-therapy-per-le-malattie-rare-un-passo-avanti-verso-la-best-practice-idN18 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Emoglobinuria-parossistica-notturna-ALXN1210-arriva-in-Europa-idN17 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Leucemia-linfoblastica-acuta-approvazione-UE-per-blinatumomab-nei-pazienti-pediatrici-idN16 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Eculizumab-nella-neuromielite-ottica-dati-positivi-dallo-studio-PREVENT-idN14 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Sclerosi-multipla-ocrelizumab-sara-erogato-dal-Servizio-Sanitario-Nazionale-in-ambito-ospedaliero-idN15 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Lumasiran-per-il-trattamento-della-iperossaluria-primaria-di-tipo-1-idN13 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Porpora-trombotica-trombocitopenica-acquisita-caplacizumab-ottiene-lapprovazione-europea-idN12 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Porfirie-epatiche-acute-risultati-positivi-per-givosiran-idN11 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/MAKEtoCARE-linnovazione-tecnologica-per-una-vita-migliore-idN9 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Amiloidosi-AL-nuova-indicazione-terapeutica-per-pomalidomide-idN10 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Rachitismo-ipofosfatemico-X-linked-approvazione-FDA-per-burosumab-idN5 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Nasce-lo-SMALab-ricerca-formazione-e-network-per-affrontare-la-rivoluzione-in-atto-nellatrofia-muscolare-spinale-idN6 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Migalastat-migliora-la-diarrea-nei-pazienti-con-malattia-di-Fabry-idN7 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Lombardia-aggiornamento-della-Rete-Regionale-per-le-malattie-rare-idN8 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Emicizumab-per-il-trattamento-dellemofilia-A-idN1 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Alfa-mannossidosi---nuova-terapia-enzimatica-idN2 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Nusinersen-nuovi-dati-per-latrofia-muscolare-spinale-SMA-idN3 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Migalastat-per-il-trattamento-della-malattia-di-Fabry-idN4 0.40 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/linkUtili/ 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/contatti/ 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/download/2026_2/MR_2_2026.pdf 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/Due-reti-un-sistema-sanitario-cosa-la-Rete-Trapianti-pu-insegnare-alla-Rete-Malattie-Rare-idA346 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/Protei-chimere-e-basilischi-lintricato-mondo-delle-malattie-istiocitarie-idA347 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/Perch--cos-difficile-la-comunicazione-con-i-pazienti-stranieri-idA348 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/Malattie-rare-e-trapianto-dalla-selezione-del-ricevente-alla-valutazione-del-donatore-idA349 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/I-criteri-di-valutazione-e-di-autorizzazione-delle-diverse-entit-regolatorie-differenze-tra-Paesi-europei-idA350 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/Linfoadeniti-necrotizzanti-recidivanti-e-aortite-come-esordio-di-istiocitosi-sistemica-BRAF-mutata-idA351 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/IpoPTH-post-chirurgico-complesso-dal-fallimento-della-terapia-convenzionale-alla-stabilizzazione-metabolica-con-palopegteriparatide-idA352 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/Calcificazione-caseosa-dellanulus-mitralico-diagnosi-radiologica-differenziale-di-una-rara-massa-cardiaca-pseudo-neoplastica-idA353 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/La-sindrome-di-Wiedemann-Steiner-idA354 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/Istiocitosi-novit-nel-trattamento-farmacologico-idA355 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/Disuguaglianze-di-genere-nel-percorso-clinico-delle-malattie-rare-evidenze-e-strumenti-innovativi-idA356 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/rivista/AIRI-ventanni-al-fianco-dei-pazienti-nella-lotta-alle-istiocitosi-idA357 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/download/q_2023_1/Q_1_2023.pdf 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Sclerodermia-terapie-rivoluzionarie-ma-la-diagnosi-tarda-ancora-di-5-7-anni-idN367 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Medicina-personalizzata-e-AI-i-successi-del-progetto-ANTHEM-per-le-malattie-rare-idN366 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Sindrome-di-Rett-dal-CHMP-parere-positivo-per-trofinetide-idN364 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Angioedema-ereditario-parere-positivo-del-CHMP-per-lestensione-pediatrica-di-berotralstat-idN365 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Women-in-Rare-il-Libro-Bianco-sul-ritardo-diagnostico-idN363 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/news/Women-in-Rare-il-Libro-Bianco-sul-ritardo-diagnostico-idN362 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/privacyPolicy/ 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/cookiesPolicy/ 0.80 2026-07-28T14:42:31+02:00 https://www.malattierare.eu/pages/terminiCondizioni/ 0.80 2026-07-28T14:42:31+02:00